Published in
Elsevier, European Journal of Cancer, 10(51), p. 1321-1330, 2015
DOI: 10.1016/j.ejca.2015.03.025
Links
Tools
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
Journal article published in 2015 by
Linda Dirven,
Martin J. van den Bent,
Andrew Bottomley,
Nelly van der Meer,
Bronno van der Holt 
,
Maaike J. Vos,
Annemiek M. E. Walenkamp,
Laurens V. Beerepoot,
Monique C. J. Hanse,
Jaap C. Reijneveld,
Aja Otten,
Filip Y. F. L. de Vos ,
Marion Smits,
Jacoline E. C. Bromberg,
Walter Taal
and other authors.
,
Maaike J. Vos,
Annemiek M. E. Walenkamp,
Laurens V. Beerepoot,
Monique C. J. Hanse,
Jaap C. Reijneveld,
Aja Otten,
Filip Y. F. L. de Vos ,
Marion Smits,
Jacoline E. C. Bromberg,
Walter Taal
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 